Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis

Zihui Liu, Yiting Gu, Huanfang Fan, Mao Huang, Dehui Li, Wen Guo, Yun He, Shuang Zhang · 2026

Read Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis by Zihui Liu, Yiting Gu, Huanfang Fan, Mao Huang, Dehui Li, Wen Guo, Yun He, Shuang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359405.txt.

Description

Zihui Liu and eight colleagues wrote this 2026 PLOS ONE research article on esophageal cancer. The cancer studied is squamous cell carcinoma of the food pipe, tested in cell cultures and in TE-1 xenografts, tumors grown in animals. The treatment under study is Shenling Qige Granules, a traditional Chinese medicine preparation.

As the title states, the granules inhibit the cancer's progression in these models by acting on a chain of molecular signals that runs from DCN through TGF-β to Smad. Showing a mechanism, not just an effect, helps judge whether a traditional remedy deserves clinical testing. Researchers working where traditional and modern cancer medicine meet are the audience.

Catalog record

CREATORZihui Liu, Yiting Gu, Huanfang Fan, Mao Huang, Dehui Li, Wen Guo, Yun He, Shuang Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE74649
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0359405

Browse the full library · About the Tower of Babel